🎉 Exciting Milestone: Preprints.org Hits 70,000 Preprints! 📌 A heartfelt thank you to all the scholars and researchers for your invaluable contributions. Together, we're propelling #OpenScience forward. 📚 Keep empowering your research journey with us! 🌟 #Preprints #Research #AcademicCommunity
Preprints.org
Book and Periodical Publishing
Basel, Switzerland 1,723 followers
Preprints is a platform dedicated to making early versions of research outputs permanently available and citable.
About us
Preprints.org is a multidiscipline platform providing preprint service that is dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors as long as the updated content has not been published online. Content on Preprints is not peer-reviewed and can receive feedback from readers. For any inquiries related to Preprints, please contact info@preprints.org
- Website
-
https://www.preprints.org/
External link for Preprints.org
- Industry
- Book and Periodical Publishing
- Company size
- 5,001-10,000 employees
- Headquarters
- Basel, Switzerland
- Specialties
- Preprint, Science, and Multidisciplinary
Updates
-
🕵️♂️🖥️ Advanced persistent threats (APTs) are like the elite ninjas of the cyber world—sophisticated, stealthy, and often politically or financially driven. Blue teams usually dig through server logs and firewall rules, but attackers think in graphs. So, what's the game plan? By analyzing 40,358 pages of #APT reports with graph-based algorithms, Mr. Burak GÜLBAY and Dr. Mehmet Demirci uncover critical APT groups and indicators of compromise (IoC). 🔐 With this framework, they're not just playing defense—they're anticipating the moves of the cyber ninjas. Congratulations on hitting 100 preprint downloads in just two weeks! 🎉 Read the full text: https://lnkd.in/g8vin7xy #CyberSecurity #GraphAlgorithms Gazi Üniversitesi Fen Bilimleri Enstitüsü
-
-
Effective #leadership and a strong organizational culture aren't just buzzwords—they're crucial for success. Unlike traditional top-down approaches, distributed leadership fosters a more democratic and participatory environment, where decision-making is a team effort. 🤝 Mr. David Debono et al developed a model illustrating how leadership and culture intertwine to boost effectiveness. Check out more findings and get ahead in small enterprise management: https://lnkd.in/g8_vB6Za
-
-
🦠💉 The advent of mRNA vaccines for SARS-CoV-2 marks a groundbreaking leap in #vaccine technology. However, some experts are waving a caution flag about possible side effects on our gut microbiota (GM). 🧫 The preprint by Dr Mark Fabrowski, Dr. Carlo Brogna and colleagues proposes an experimental protocol to test this hypothesis, aiming to uncover any hidden impacts on our gut microbiome. https://lnkd.in/g6k4gjvf #Microbiome #mRNAVaccines #GutHealth #SARSCoV2
-
-
🌳 Paris, Tokyo, Beijing, and Barcelona are rocking the “green spots” while some Olympic villages are real “hotspots”. 🏙️ ♨ Using Landsat data and Google Earth Engine, Dr. Joan-Cristian Padró Garcia et al's latest preprint mapped the highs and lows from Paris ’24 to Montreal ’76 and explored the impact of #Olympic urban planning on land surface temperatures. https://lnkd.in/g5rDM9pC #Paris2024 #UrbanPlanning #GIS Universitat Autònoma de Barcelona
-
-
🦠💉 In a recent phase 1-2 clinical trial, researchers tested the safety and effectiveness of two Cuban COVID-19 vaccines—Mambisa (intranasal) and Abdala (intramuscular)—to boost immunity in convalescent adults. With 1161 participants across multiple centers, this randomized, open-label trial aimed to see if these #vaccines could up the ante for those who’ve already had COVID-19. https://lnkd.in/gaa8Whcf #COVID19 #VaccineResearch #Immunology
-
-
Gestational trophoblastic diseases (GTDs) present a complex spectrum, from benign molar pregnancies to malignant neoplasms. 🧬 By sifting through 65 studies, Prof. Dr. Rajani Dube et al's review uncovers how these molecular missteps turn benign moles into potentially malignant forms, offering a sneak peek into the mechanisms of #GTD and their implications for tailored treatments. 🔗 https://lnkd.in/gcM6rcFM #MolecularBiology #CancerResearch
-
-
Preprints.org reposted this
🍃🔍 Ensuring healthy mulberry yields is critical, and the enhanced detection algorithm, #YOLOv8-RFMD, promises to revolutionize disease detection in natural environments. Why? YOLOv8-RFMD integrates MDFA and RFMD modules for precise detection of small lesions on mulberry leaves. 🌿 Can this advanced technology streamline mulberry leaf disease management globally? Share your insights! https://lnkd.in/gy8HRzBi #AgTech #CropProtection #DiseaseDetection #InnovationInAgriculture
-
-
📡 Traditional Orthogonal Multiple Access (OMA) systems just won't cut it anymore. Enter Non-Orthogonal Multiple Access (NOMA) and other cutting-edge technologies like MIMO, IRS, UAVs, and Energy Harvesting (HV). 🌐🚀 Review by Mr. Yasir Al-Ghafri, Dr. Hafiz Asif, Dr. Naser Tarhuni and Dr. Zia Nadir dives deep into how these innovations enhance spectral efficiency and communication reliability, even in the most obstacle-filled environments. Whether it's Cooperative #NOMA (C-NOMA) or Intelligent Reflective Surfaces (IRS), the future of connectivity looks not only faster but also greener. 🔋 https://lnkd.in/g4vKbX4h Sultan Qaboos University #5G #WirelessTech #Innovation #SustainableTech
-
-
🧬 B-cell lymphoid malignancies are like the sneaky villains of the hematologic cancer world, and BTK inhibitors were the heroes we thought would save the day. But alas, even heroes have their nemeses. The evolving battle against BTK inhibitor resistance is heating up, and with these new strategies, the quest for a cure continues. https://lnkd.in/gHbQvSpJ #CancerResearch #BCellMalignancies #BTKInhibitors #Biotech
-